Am J Transplant, Volume 19, Suppl 3 Archives - Page 115 of 214 - ATC Abstracts

2019 American Transplant Congress
Outcomes of Renal Transplantation in Elderly Patients Older Than 60 Years of Age
R. Yemini¹, E. Nesher², R. Rahamimov³, S. Eizner², V. Mazhybovsky², V. Tennak², M. Gurevich², R. Ghinea², E. Mor²
¹Department of Surgery, Assuta Ashdod Medical Center, Ashdod, Israel, ²Department of Transplant Surgery, Beilinson Medical Center, Petach-Tikva, Israel, ³Department of Nephrology, Beilinson Medical Center, Petach-Tikva, Israel
*Purpose: Patients ≥ 60 years are the largest growing age group which comprise 40% of all patients with ESRD. Kidney transplantation has been shown to…
2019 American Transplant Congress
Induction Therapy in Elderly Kidney Transplant Recipients with Low Immunological Risk
C. Masset¹, J. Boucquemont², V. Garrigue³, M. Ladrière⁴, F. Buron⁵, E. Cassuto⁶, Y. Foucher², J. Dantal¹
¹University Hospital of Nantes, Nantes, France, ²University of Nantes, Nantes, France, ³University Hospital of Montpellier, Montpellier, France, ⁴University Hospital of Nancy, Nancy, France, ⁵University Hospital of Lyon, Lyon, France, ⁶University Hospital of Nice, Nice, France
*Purpose: Thymoglobulin (ATG) and Basiliximab (BSX) lead to similar rejection rates in low immunological risk patients. ATG seems to be associated with infectious and malignancy…
2019 American Transplant Congress
Type of Induction Does Not Impact Patient or Kidney Allograft Survival in Simultaneous Liver and Kidney Transplant Recipients in the United States
S. Riad¹, N. Lim², S. Jackson³, J. Lake²
¹University of Minnesota, Minneapolis, MN, ²Medicine, University of Minnesota, Minneapolis, MN, ³Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction practices vary widely in the United States for patients undergoing simultaneous liver and kidney (SLK) transplantation. We examined the impact of induction type…
2019 American Transplant Congress
Association of Induction Immunosuppression Agents with Incidence of Cytomegalovirus Infection Following Kidney Transplantation
S. A. Medani, B. C. Astor, A. Djamali, M. A. Mohamed
Medicine- Nephrology, University of Wisconsin, Madison, WI
*Purpose:Cytomegalovirus (CMV) is the most common opportunistic infection following renal transplantation and can lead to significant morbidity. Inconsistency in adjusting for donor/recipient pre transplant CMV serostatus and in Alemtuzumab dosing probably contributed to…
2019 American Transplant Congress
Effect of Influenza Vaccine in Patients with Kidney Transplant during 2017/2018
K. Tsujimura¹, M. Ota¹, H. Ishida², K. Tanabe²
¹Surgery, Tomishiro Central Hospital, Okinawa, Japan, ²Urology, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: This study aimed to evaluate the effect of influenza vaccine in kidney transplant recipients during the 2017/2018.*Methods: We retrospectively assessed 136 patients who underwent…
2019 American Transplant Congress
Post-Transplant Functional Status Trajectory among Adult Kidney Transplant Recipients
N. Chu, Z. Shi, H. Ying, C. Haugen, D. Segev, M. McAdams-DeMarco
Johns Hopkins University, Baltimore, MD
*Purpose: Frailty and disabilities are highly prevalent among kidney transplant (KT) recipients, but are not routinely measured in KT recipients. The Karnofsky Performance Scale (KPS)…
2019 American Transplant Congress
Better Education of Kidney Recipients and Improved Access for Donor Referrals May Lead to Higher Living Donation Rates: An Early Single Center Analysis
V. Humphreville, N. Sarabu, M. DebRoy, M. Schuster, E. Sanchez, A. Padiyar, A. Jittirat, K. Yadav, J. Rabets, A. Palanisamy, K. Chavin
University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: Disparity between the kidney waitlist and organs available continues to increase. Increasing living kidney donation may provide a solution to decreasing disparity.*Methods: In 2018…
2019 American Transplant Congress
Impact of Discards for Living Donor Kidney Transplantation in Center Transplant Program
H. Villafuerte¹, E. De Sousa-Amorim², L. Peri³, M. Musquera³, E. Palou⁴, M. Lozano⁵, J. Cid⁵, J. Martorell⁴, J. M. Campistol², F. Oppenheimer², F. Diekmann², I. Revuelta²
¹Department of Nephrology, Hospital Clinic Lozano Blesa, Zaragoza, Spain, ²Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, ³Department of Urology, Hospital Clinic, Barcelona, Spain, ⁴Department of Immunology, Hospital Clinic, Barcelona, Spain, ⁵Department of Apheresis, Hospital Clinic, Barcelona, Spain
*Purpose: New and coming information about the risk of living kidney donors make the effort to study very carefully the option of living kidney donor…
2019 American Transplant Congress
Early Cognitive Improvement One Month after Liver Transplant Measured by the NIH Toolbox
M. Kim¹, J. D. Peipert², K. J. Reid¹, E. M. Liotta¹, M. B. Maas¹, D. R. Ganger³, P. C. Zee¹, D. P. Ladner⁴
¹Neurology, Northwestern University, Chicago, IL, ²Medical Social Sciences, Northwestern University, Chicago, IL, ³Medicine, Northwestern University, Chicago, IL, ⁴Surgery, Northwestern University, Chicago, IL
*Purpose: Cognitive impairment (CI) is highly prevalent in liver cirrhosis. Improvement after liver transplant (LT) varies among patients, diminishing the benefits of LT for some.…
2019 American Transplant Congress
Multimodal Analgesia Reduces Opioid Use after Liver Transplantation
K. Tong, W. Nolan, D. O'Sullivan, H. Kutzler
Hartford Hospital, Hartford, CT
*Purpose: The study aimed to determine if multi-modal pain management (MPM) can reduce opioid use in patients post-liver transplant.*Methods: This was a retrospective review of…